CEO of Cel-sci Corp (30-Year Financial, Insider Trades) Geert R Kersten (insider trades) bought 4,617 shares of CVM on 02/26/2020 at an average price of $10.83 a share. The total cost of this purchase was $50,002.
CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. CEL-SCI Corp has a market cap of $394.508 million; its shares were traded at around $10.83 . CEL-SCI Corp had annual average EBITDA growth of 46.10% over the past five years. GuruFocus has detected 1 severe warning sign with CEL-SCI Corp. .
CEO Recent Trades:
- CEO Geert R Kersten bought 4,617 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
Directors and Officers Recent Trades:
- Director Robert Eugene Watson bought 923 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
- Director Bruno Jean-marie Baillavoine bought 923 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
- Director Peter R Young bought 923 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
- Senior Vice President Daniel H Zimmerman bought 923 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
- Senior Vice President Patricia B Prichep bought 1,847 shares of CVM stock on 02/26/2020 at the average price of $10.83. The price of the stock has decreased by 0% since.
For the complete insider trading history of CVM, click here
.
